title: Selection of treatment modalities for Budd-Chiari Syndrome in China: a preliminary survey of published literature.
abstract: OBJECTIVE
  To evaluate the frequency of use of various treatment modalities for Budd-Chiari syndrome (BCS) in China by conducting a preliminary survey of relevant literature.
  
  
  METHODS
  All papers regarding the treatment of BCS in Chinese patients were identified by searching PubMed, Chinese Scientific and Technological Journal, and China National Knowledge Infrastructure databases. Data regarding the number of BCS patients treated with different treatment modalities over time were collected. The proportions of BCS patients undergoing various treatment modalities were calculated.
  
  
  RESULTS
  Overall, 300 of 3005 papers initially retrieved were included. These papers included 23352 BCS patients treated with different treatment modalities. The treatment modalities include surgery (n = 8625), interventional treatment (n = 13940), surgery combined with interventional treatment (n = 363), medical therapy (n = 277), other treatments (n = 91), and no treatment (n = 56). After 2005, the number of BCS patients treated with surgery was drastically decreased, but the number of BCS patients who underwent interventional treatment was almost maintained. Shunt surgery was the most common type of surgery (n = 3610). Liver transplantation was rarely employed (n = 2). Balloon angioplasty with or without stenting was the most common type of interventional treatment (n = 13747). Transjugular intrahepatic portosystemic shunt was rarely employed (n = 81).
  
  
  CONCLUSIONS
  Selection of treatment modalities for BCS might be different between China and Western countries. Further work should be necessary to establish a unanimous therapeutic strategy for BCS in China.
authors.affiliation: Xing-Shun Qi, Wei-Rong Ren, Dai-Ming Fan, Guo-Hong Han, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an 710000, Shaanxi Province, China.
authors.forename: Xing-Shun
authors.initials: XS
authors.lastname: Qi
authors.affiliation: Xing-Shun Qi, Wei-Rong Ren, Dai-Ming Fan, Guo-Hong Han, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an 710000, Shaanxi Province, China.
authors.forename: Wei-Rong
authors.initials: WR
authors.lastname: Ren
authors.affiliation: Xing-Shun Qi, Wei-Rong Ren, Dai-Ming Fan, Guo-Hong Han, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an 710000, Shaanxi Province, China.
authors.forename: Dai-Ming
authors.initials: DM
authors.lastname: Fan
authors.affiliation: Xing-Shun Qi, Wei-Rong Ren, Dai-Ming Fan, Guo-Hong Han, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an 710000, Shaanxi Province, China.
authors.forename: Guo-Hong
authors.initials: GH
authors.lastname: Han
mesh_terms: D000800:Angioplasty, Balloon / Q000295:instrumentation; D006502:Budd-Chiari Syndrome / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy*; D002681:China / Q000453:epidemiology; D003131:Combined Modality Therapy; D006801:Humans; D016031:Liver Transplantation; D015607:Stents; D016896:Treatment Outcome; D014656:Vascular Surgical Procedures
keywords: Budd-Chiari syndrome; Percutaneous recanalization; Surgery; Transjugular intrahepatic portosystemic shunt; Treatment